Ozempic risk: could weight loss injections be fatal? | 60 Minutes Australia
TLDRThe video script discusses the controversial drug AIC, originally developed for diabetes treatment but has gained popularity due to its side effect of significant weight loss. The drug's widespread use, especially among non-diabetics and Hollywood celebrities, has raised concerns among experts who warn of potentially fatal side effects. The story highlights the tragic case of Trish, who died after using AIC for weight loss in preparation for her daughter's wedding. Despite warnings from the TGA against prescribing AIC for weight loss, doctors continue to do so, leading to a global shortage of the drug. The script also explores the role of online telehealth companies like Juniper in facilitating easy access to AIC, raising ethical questions about the lack of safeguards and the potential risks to patients with eating disorders. The TGA is urging those who have experienced adverse effects from AIC to come forward to aid in safety monitoring, emphasizing the importance of doctors fully informing patients about the risks associated with these medications.
Takeaways
- π The drug AIC, originally developed for diabetes treatment, gained popularity due to its side effect of dramatic weight loss.
- π AIC's popularity surged when Hollywood celebrities began using it, leading to a significant increase in demand.
- β οΈ Experts are warning of a potentially fatal side effect from unsupervised use of AIC, which could lead to death.
- π’ Roy Webster lost his wife Trish, who died after using AIC to lose weight for her daughter's wedding, despite not having diabetes.
- π¨ The drug's manufacturer, noo Nordisk, is facing a lawsuit regarding alleged side effects, and recent deaths have prompted the FDA to change product information.
- π The TGA (Therapeutic Goods Administration) in Australia is investigating local cases and considering warnings for severe gastrointestinal illness associated with AIC.
- π₯ Some doctors are prescribing AIC off-label for weight loss, despite TGA advice against it, raising concerns about patient safety.
- π‘ Endocrinologist Dr. Katherine Williams explains that while the active ingredient in AIC can cause digestive issues, the absolute risk is very low, but not non-existent.
- π° The accessibility of AIC through online telehealth companies like Juniper has raised ethical concerns about the ease of obtaining the drug for cosmetic purposes.
- π Juniper, a major provider of AIC, has grown rapidly and generates significant revenue, but its practices are questioned for potentially contributing to a global shortage of the drug.
- π‘οΈ There is a call for stronger regulation and safeguards to prevent misuse of medications like AIC, especially considering their potential risks.
Q & A
What was the original purpose of the drug AIC?
-AIC was originally developed to help in the treatment of diabetes.
What side effect of AIC led to its popularity explosion?
-The side effect of dramatic weight loss contributed to the drug's popularity.
What is the name of the man who lost his wife due to the use of AIC?
-Roy Webster lost his wife, Trish, after she used AIC.
What was the cause of Trish Webster's death as stated on her death certificate?
-Trish Webster's death certificate states the cause was acute gastrointestinal illness.
What is the active ingredient in AIC that is designed to mimic the GLP-1 hormone?
-Semaglutide is the active ingredient in AIC that mimics the GLP-1 hormone.
What is the role of the GLP-1 hormone in digestion?
-The GLP-1 hormone tells us when we're full, aiding in digestion.
Why is Dr. Katherine Williams concerned about the use of AIC for cosmetic weight loss?
-Dr. Katherine Williams is concerned because it distracts from the real conversation about the drug's impact on disease and people's lives who really need it.
What is the name of the company that is the single biggest provider of AIC?
-Juniper is the single biggest provider of AIC.
What is the process for obtaining AIC through Juniper's online telehealth service?
-Patients sign up, complete a screening quiz, talk to a doctor on the phone, and if appropriate, are prescribed medication which is then facilitated through partner pharmacies.
What is the concern raised by Professor Elizabeth Scott regarding online providers like Juniper?
-Professor Scott is concerned that it's too easy for patients to lie and access AIC when they shouldn't, as there aren't enough safeguards to protect people.
What is the position of the TGA regarding the prescription of AIC for weight loss?
-The TGA has warned not to give out AIC for weight loss and expects doctors to inform their patients about the dangers.
Outlines
π The Rise and Risks of Drug AIC - A Weight Loss Revolution?
The first paragraph introduces the drug AIC, initially developed for diabetes treatment but which gained popularity due to its unintended side effect of significant weight loss. The narrative describes how the drug's use escalated, particularly after Hollywood celebrities endorsed it. It then shifts to a tragic story of Roy Webster, whose wife Trish died unexpectedly, which he attributes to her use of AIC. The paragraph also mentions the concerns raised by experts about the potential for fatal side effects from unsupervised use of the drug.
π¨ Warnings and Reactions to AIC's Side Effects
The second paragraph delves into the consequences of using AIC, highlighting Trish's tragic death and the broader implications for the pharmaceutical industry. It discusses the legal actions against the manufacturers of AIC and similar drugs, the regulatory changes prompted by recent deaths, and the TGA's investigation into local cases. The narrative also includes perspectives from healthcare professionals regarding the drug's mechanism, its appropriate use, and the risks associated with its misuse.
π° The Business of Weight Loss Drugs and Accessibility Concerns
The third paragraph explores the business side of weight loss drugs, focusing on Tim Doyle's telehealth company, Juniper, which has become a major provider of AIC. It outlines the process through which patients can obtain the drug via online platforms, raising concerns about the potential for misuse and the ethical considerations of such practices. The paragraph also touches on the experiences of patients like Andrew, who found the drug beneficial, and the dangers it poses to individuals with pre-existing eating disorders.
π‘οΈ The Ethical and Regulatory Challenges of AIC
The final paragraph addresses the ethical and regulatory challenges surrounding the prescription and use of AIC. It includes commentary from medical professionals who express concern about the ease with which patients can obtain the drug and the potential for it to fall into the wrong hands. The narrative concludes with a call for better regulation and safeguards to protect patients, and a personal story from Roy Webster, who lost his wife to the drug, advocating for increased awareness of its risks.
Mindmap
Keywords
π‘AIC
π‘Weight Loss
π‘Gastrointestinal Illness
π‘Off-Label Prescribing
π‘Hollywood Celebrities
π‘Regulation
π‘Juniper
π‘Obesity
π‘Eating Disorders
π‘Pharmacotherapy
π‘Global Shortage
Highlights
Drug AIC, originally developed for diabetes treatment, gained popularity for its side effect of dramatic weight loss.
The use of AIC has been linked to severe gastrointestinal illness, which may lead to death.
Hollywood celebrities' use of AIC has contributed to its widespread popularity and demand.
Roy Webster's wife, Trish, died after using AIC for weight loss, leading to calls for better regulation and warnings.
Trish lost 16 kilos in 5 months using AIC and Saxenda, but experienced severe side effects.
The TGA and FDA are investigating cases and have updated warnings for AIC and similar drugs.
Novo Nordisk, the manufacturer of AIC, acknowledges post-marketing reports of gastrointestinal side effects.
Semaglutide, the active ingredient in AIC, mimics the GLP-1 hormone to reduce hunger and manage blood sugar.
Dr. Katherine Williams discusses the potential for AIC to cause digestive complications and the need for caution.
Andrew, a patient with severe obesity, lost 20 kilos using a drug similar to AIC, highlighting its potential benefits for certain individuals.
Tim Doyle's telehealth company Juniper has become the largest provider of AIC, raising ethical concerns about accessibility.
Juniper's process for prescribing AIC involves an online quiz, phone consultation, and photo upload, raising questions about patient verification.
Sam, living with anorexia, expresses concern about the ease of accessing AIC and its potential to exacerbate eating disorders.
Professor Elizabeth Scott warns of the risks of online providers making it easy to lie and access AIC inappropriately.
Regulators warn of a global shortage of AIC due to its unregulated use for cosmetic weight loss.
Tim Doyle defends his company's practices, stating they support patients' weight loss journeys ethically.
The TGA is calling for people who have experienced adverse effects from AIC to contact them for safety monitoring.
Roy Webster seeks a coronial inquest into his wife's death to raise awareness of the risks of weight loss injections.
Transcripts
Browse More Related Video
The effects of Ozempic and other weight loss injections | 60 Minutes Australia
Katie Couric discusses "celebrity weight loss drug," Ozempic with obesity expert and Dr. Lou Aronne
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
#405 Obesity Medicine, GLP1 agonists, Weight Loss Management Tools and Tips
Do Ketogenic Diets Really Work?
Ivermectin and vaccine injury
5.0 / 5 (0 votes)
Thanks for rating: